Tags |
|
|
Links |
|
|
Main Subject - Human Resources
The initial cost of training a new graduate is estimated at approximately $
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
40 000 per year. Therefore, if a new employee quits in the first few years,
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
the company experiences a considerable net loss.
It is very important to
It is very important to
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
have good level of HRM.
Human resource management is very important in pow
Human resource management is very important in pow
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
erful firms, usually HRM manager is a board member. For instance, in Swatch
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
group president of the board is the HRM manager. That means that HRM is we
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ll recognized in modern companies. HRM is the future and moto of HRM is: Wh
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
en worker is talking, manager listens!
Another way to put this is that the
Another way to put this is that the
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
human resource management needs to provide a high return on the business’s
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
investment in its people. This makes it a highly complex function – becaus
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
it deals with not just management issues but human ones as well.
Human re
Human re
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
sources are responsible for tying incentives and rewards to certain positio
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ns and roles in order to maximize performance levels. This is a strategic t
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
hinking task because it affects every single person in the organization and
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
has to be planned separately for each position, depending on level, depart
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ment and goals. Some jobs need to be more goal driven, such as sales so sal
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ary can be basic but commission can form the bulk of the remuneration, lead
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ing to more incentive to work effectively and close sales. Some firms tie t
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
op management’s salary to stock price but this can be risky. It is up to hu
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
man resources to structure this important aspect to everyone’s satisfaction
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/8477/mainsubjects-Human-Resources.html">Human Resources</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/8477/mainsubjects-Human-Resources.html]Human Resources[/url]
Related Articles:
Why You Should Agree With Royalty Fees
Organized To Be Your Best! - A Book Summary
Bookmark it:
|